After reading the entire review, I would agree with the authors and I
feel there must be areas and specialities to defined and considered where
this system can be used. For example, using it for pharmacy practice in
few places will bring in a high potential of false prognosis as per lesser
knowledge of individuals.
I would suggest a more wider studies with a summarised meta-analysis,
where the use of this system...
After reading the entire review, I would agree with the authors and I
feel there must be areas and specialities to defined and considered where
this system can be used. For example, using it for pharmacy practice in
few places will bring in a high potential of false prognosis as per lesser
knowledge of individuals.
I would suggest a more wider studies with a summarised meta-analysis,
where the use of this system can be seen in different areas and their
potential towards its successful use as per outcomes achieved.
Dr. Sharma: You've hit upon multiple issues that certainly
complicate the innovation process. Subjectivity, bias, conflicting
interests, and stakeholder resistance can all prevent worthwhile needs
from being addressed and valuable solutions from reaching the market. Our
hope is that by taking a systematic approach to medtech invention,
innovators will at least be able to anticipate these potential roadblocks
and more...
Dr. Sharma: You've hit upon multiple issues that certainly
complicate the innovation process. Subjectivity, bias, conflicting
interests, and stakeholder resistance can all prevent worthwhile needs
from being addressed and valuable solutions from reaching the market. Our
hope is that by taking a systematic approach to medtech invention,
innovators will at least be able to anticipate these potential roadblocks
and more effectively manage them. Thank you for your comments.
After reading the entire review, I would agree with the authors and I feel there must be areas and specialities to defined and considered where this system can be used. For example, using it for pharmacy practice in few places will bring in a high potential of false prognosis as per lesser knowledge of individuals.
I would suggest a more wider studies with a summarised meta-analysis, where the use of this system...
Dr. Sharma: You've hit upon multiple issues that certainly complicate the innovation process. Subjectivity, bias, conflicting interests, and stakeholder resistance can all prevent worthwhile needs from being addressed and valuable solutions from reaching the market. Our hope is that by taking a systematic approach to medtech invention, innovators will at least be able to anticipate these potential roadblocks and more...
Pages